lincomycin has been researched along with cefazolin in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (40.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 1 (10.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Duewelhenke, N; Eysel, P; Krut, O | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Ezaki, T; Imamura, H; Kobata, S; Ninomiya, K; Suzuki, S; Ueno, K; Watanabe, I; Watanabe, K | 1 |
Debeaumont, D; Mackey, D; Varlet, A | 1 |
Kramár, R; Málek, P; Modr, Z; Morávek, J | 1 |
Galagudza, M; Golovkin, A; Korolev, D; Krutikov, A; Kulagina, O; Mishanin, A; Shulmeyster, G; Shumilo, M; Spiridonova, A | 1 |
1 review(s) available for lincomycin and cefazolin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 other study(ies) available for lincomycin and cefazolin
Article | Year |
---|---|
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
[Josamycin: antibacterial activity against anaerobes (author's transl)].
Topics: Anti-Bacterial Agents; Bacteroides; Cefazolin; Cephalexin; Cephaloridine; Clindamycin; Drug Resistance, Microbial; Erythromycin; Fusobacterium; Leucomycins; Lincomycin | 1978 |
Septicaemia.
Topics: Cefazolin; Cephaloridine; Cephalothin; Cephradine; Clindamycin; Drug Resistance, Microbial; Flucytosine; Gentamicins; Humans; Lincomycin; Metronidazole; Sepsis; Shock, Septic; Tobramycin | 1975 |
Antibiotic loaded plaster of Paris pellets: an in vitro study of a possible method of local antibiotic therapy in bone infection.
Topics: Anti-Bacterial Agents; Calcium Sulfate; Cefazolin; Fusidic Acid; Gentamicins; Humans; In Vitro Techniques; Lincomycin; Methylmethacrylate; Methylmethacrylates; Osteomyelitis; Staphylococcus aureus | 1982 |
Infection in vascular prosthesis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Blood Coagulation; Blood Vessel Prosthesis; Cefazolin; Humans; Lincomycin; Postoperative Complications; Premedication; Preoperative Care; Rabbits; Tobramycin | 1980 |
Hemolytic Activity, Cytotoxicity, and Antimicrobial Effects of Silver Nanoparticles Conjugated with Lincomycin or Cefazolin.
Topics: Anti-Bacterial Agents; Cefazolin; Lincomycin; Metal Nanoparticles; Microbial Sensitivity Tests; Silver | 2022 |